Showing results (181-190 of 697) with videos related to
Sort By:
Pageof 70
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME StudyP E Morange, D A Tregouet, C Frere, et al.Thrombosis and Haemostasis|July 1, 1995
Fibrinolytic agents: mechanisms of activity and pharmacologyH R Lijnen, D CollenArteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH studyP E Morange, N Saut, M C Alessi, et al.Enzyme|January 1, 1988
Mechanisms of plasminogen activation by mammalian plasminogen activatorsH R Lijnen, D CollenAnnals of the New York Academy of Sciences|December 4, 1992
Remaining perspectives of mutant and chimeric plasminogen activatorsH R Lijnen, D CollenAdvances in Experimental Medicine and Biology|January 1, 1990
New developments in thrombolytic therapyD Collen, H K GoldBlood|December 1, 1981
The presence and release of alpha 2-antiplasmin from human plateletsE F Plow, D CollenArteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2009
The tissue-type plasminogen activator storyD Collen, H R LijnenPageof 70